There is indeed the “the more advanced/aggressive tumor, the lower ACKR4 expression” trend, but as it concerns normal tissue, the normal-to-expression rate shows apparently less downregulated ACKR4 in more advanced/aggressive cancers. The gene discussed is ACKR4; the disease is cancer.